149 related articles for article (PubMed ID: 2464975)
1. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
Lai YS; Thung SN; Gerber MA; Chen ML; Schaffner F
Arch Pathol Lab Med; 1989 Feb; 113(2):134-8. PubMed ID: 2464975
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemistry of cytokeratins in primary human liver tumors.
Van Eyken P; Sciot R; Desmet VJ
APMIS Suppl; 1991; 23():77-85. PubMed ID: 1715730
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
Brunt EM; Swanson PE
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S53-61. PubMed ID: 1374219
[TBL] [Abstract][Full Text] [Related]
4. Expression of sialylated Lewis(x) antigen in chronic and neoplastic liver diseases.
Jagirdar J; Thung SN; Shah KD; Nudelman E; Singhal A; Paronetto F
Arch Pathol Lab Med; 1992 Jun; 116(6):643-8. PubMed ID: 1352099
[TBL] [Abstract][Full Text] [Related]
5. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
[TBL] [Abstract][Full Text] [Related]
8. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
[TBL] [Abstract][Full Text] [Related]
9. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
10. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic neoductules].
Fischer HP; Meybehm M; Zhou H; Schoch J
Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
[TBL] [Abstract][Full Text] [Related]
12. Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells.
Schmitt-Graeff A; Jing R; Nitschke R; Desmoulière A; Skalli O
Hum Pathol; 2006 Sep; 37(9):1200-10. PubMed ID: 16938526
[TBL] [Abstract][Full Text] [Related]
13. Expression of Lewis blood group antigens in cancerous and non-cancerous liver.
Kanai T; Hirohashi S; Upton MP; Ino Y; Shimosato Y
Jpn J Cancer Res; 1987 Sep; 78(9):968-76. PubMed ID: 2822639
[TBL] [Abstract][Full Text] [Related]
14. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.
Van Eyken P; Sciot R; Desmet VJ
Histopathology; 1989 Aug; 15(2):125-35. PubMed ID: 2476370
[TBL] [Abstract][Full Text] [Related]
15. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
Fischer HP; Altmannsberger M; Weber K; Osborn M
Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
[TBL] [Abstract][Full Text] [Related]
16. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis.
Tsuneyama K; Yasoshima M; Harada K; Hiramatsu K; Gershwin ME; Nakanuma Y
Hepatology; 1998 Sep; 28(3):620-3. PubMed ID: 9731549
[TBL] [Abstract][Full Text] [Related]
17. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of alpha 1-antitrypsin in hepatomas.
Reintoft I; Hägerstrand I
Arch Pathol Lab Med; 1979 Sep; 103(10):495-8. PubMed ID: 223516
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma.
Johnson DE; Herndier BG; Medeiros LJ; Warnke RA; Rouse RV
Am J Surg Pathol; 1988 Mar; 12(3):187-97. PubMed ID: 2449824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
